AOC3 and myocardial infarction: Additionally, myocardial SSAO activity was increased in myocardial ischemia-reperfusion injury, and administration of SCZ, hydralazine, or LJP-1207, reduced the myocardial infarct size in vivo (Yang et al., 2011).